Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Livermore

Showing results (561-570 of 807) with videos related to

Pageof 81
Sort By:
The Journal of Antimicrobial Chemotherapy|August 14, 2014
Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108,717 clinical isolates from primary, secondary and tertiary care patients in LondonLuke S P Moore, Rachel Freeman, Mark J Gilchrist, et al.
Advances in Biological Regulation|November 16, 2021
The inositol pyrophosphate metabolism of Dictyostelium discoideum does not regulate inorganic polyphosphate (polyP) synthesisYann Desfougères, Paloma Portela-Torres, Danye Qiu, et al.
The Journal of Antimicrobial Chemotherapy|May 19, 2017
Activity of ceftolozane/tazobactam against surveillance and 'problem' Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British IslesDavid M Livermore, Shazad Mushtaq, Daniele Meunier, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 28, 2021
Emergency preparation and mitigation for COVID-19 response in an integrated pharmacy practice modelRobert A Moye, Kim Mason, Amy Flatt, et al.
Journal of Clinical Microbiology|June 11, 2010
Comparison of BD Phoenix, Vitek 2, and MicroScan automated systems for detection and inference of mechanisms responsible for carbapenem resistance in EnterobacteriaceaeNeil Woodford, Anne T Eastaway, Michael Ford, et al.
The Journal of Antimicrobial Chemotherapy|October 27, 2025
Antimicrobial resistance among agents of community-associated lower respiratory tract infection in the UK and Ireland: trends from 1999/2000 to 2018/2019Rosy Reynolds, David Felmingham, Shazad Mushtaq, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2018
Pharmacodynamics of Voriconazole for Invasive Pulmonary ScedosporiosisHelen Box, Clara Negri, Joanne Livermore, et al.
The Journal of Antimicrobial Chemotherapy|September 12, 2000
Regional variation in ampicillin and trimethoprim resistance in Escherichia coli in England from 1990 to 1997, in relation to antibacterial prescribingD M Livermore, P Stephens, J Weinberg, et al.
The Journal of Antimicrobial Chemotherapy|October 27, 2025
Antimicrobial resistance among agents of hospital-acquired lower respiratory tract infection in the UK and Ireland: trends from 2008/2009 to 2018/2019Rosy Reynolds, Ian Morrissey, Shazad Mushtaq, et al.
The Journal of Antimicrobial Chemotherapy|June 25, 2013
Vancomycin MIC as a predictor of outcome in MRSA bacteraemia in the UK contextR Hope, R M Blackburn, N Q Verlander, et al.
Pageof 81

Showing results (561-570 of 807) with videos related to

Sort By:
Pageof 81
The Journal of Antimicrobial Chemotherapy|August 14, 2014
Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108,717 clinical isolates from primary, secondary and tertiary care patients in LondonLuke S P Moore, Rachel Freeman, Mark J Gilchrist, et al.
Advances in Biological Regulation|November 16, 2021
The inositol pyrophosphate metabolism of Dictyostelium discoideum does not regulate inorganic polyphosphate (polyP) synthesisYann Desfougères, Paloma Portela-Torres, Danye Qiu, et al.
The Journal of Antimicrobial Chemotherapy|May 19, 2017
Activity of ceftolozane/tazobactam against surveillance and 'problem' Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British IslesDavid M Livermore, Shazad Mushtaq, Daniele Meunier, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 28, 2021
Emergency preparation and mitigation for COVID-19 response in an integrated pharmacy practice modelRobert A Moye, Kim Mason, Amy Flatt, et al.
Journal of Clinical Microbiology|June 11, 2010
Comparison of BD Phoenix, Vitek 2, and MicroScan automated systems for detection and inference of mechanisms responsible for carbapenem resistance in EnterobacteriaceaeNeil Woodford, Anne T Eastaway, Michael Ford, et al.
The Journal of Antimicrobial Chemotherapy|October 27, 2025
Antimicrobial resistance among agents of community-associated lower respiratory tract infection in the UK and Ireland: trends from 1999/2000 to 2018/2019Rosy Reynolds, David Felmingham, Shazad Mushtaq, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2018
Pharmacodynamics of Voriconazole for Invasive Pulmonary ScedosporiosisHelen Box, Clara Negri, Joanne Livermore, et al.
The Journal of Antimicrobial Chemotherapy|September 12, 2000
Regional variation in ampicillin and trimethoprim resistance in Escherichia coli in England from 1990 to 1997, in relation to antibacterial prescribingD M Livermore, P Stephens, J Weinberg, et al.
The Journal of Antimicrobial Chemotherapy|October 27, 2025
Antimicrobial resistance among agents of hospital-acquired lower respiratory tract infection in the UK and Ireland: trends from 2008/2009 to 2018/2019Rosy Reynolds, Ian Morrissey, Shazad Mushtaq, et al.
The Journal of Antimicrobial Chemotherapy|June 25, 2013
Vancomycin MIC as a predictor of outcome in MRSA bacteraemia in the UK contextR Hope, R M Blackburn, N Q Verlander, et al.
Pageof 81